IRMD
IRadimedDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
IRadimed achieves accelerated hospital adoption and wins multiple contracts, expanding recurring consumables revenue and improving scale economics. Positive clinical or regulatory outcomes broaden the addressable market and support meaningful multiple expansion toward the bull target.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +3.3.
What can break
Adverse reimbursement or regulatory rulings
Momentum
44
Value
50
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $99.00 · Bull $130.00 · Bear $75.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-19 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $120.00
Why
Momentum44 · Δ7d +8.3
Value50 · Δ7d -0.0
Sentiment51 · Δ7d +3.3
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
44
34% active weight
Current posture
7d trendImproving
Δ7d
+8.3
Δ21d
+21.4
Value
50
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
51
33% active weight
Current posture
7d trendImproving
Δ7d
+3.3
Δ21d
-1.5
Why this grade
Composite grade D. Momentum 43.9 / Value 50.0 / Sentiment 51.1
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$1.15B
Beta
1.10
Shares Out
12.72M
P/E (TTM)
59.6
P/S (TTM)
15.53
P/FCF (TTM)
224.78
Rev YoY
+15.7%
EPS YoY
+9.7%
Gross Margin
+77.1%
Op Margin
+30.9%
Net Debt
-$52.23M
Current Ratio
6.64
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology